EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 21 / No 3 (Mars 2005) Med Sci (Paris), 21 3 (2005) 315-319 References
Free Access
Issue
Med Sci (Paris)
Volume 21, Number 3, Mars 2005
Page(s) 315 - 319
Section M/S revues
DOI https://doi.org/10.1051/medsci/2005213315
Published online 15 March 2005
  1. Wolf S. The pharmacology of placebos. Pharmacol Rev 1959; 11 : 689–704. [Google Scholar]
  2. Shapiro AK, Shapiro E. The placebo : is it much ado about nothing. In : Harrington A, ed. The placebo effect : an interdisciplinary exploration. Cambridge : Harvard University Press, 1997 : 2–36. [Google Scholar]
  3. Lemoine P. Le mystère du placebo. Paris : Odile Jacob, 1996 : 238 p. [Google Scholar]
  4. Beecher HK. The powerful placebo. JAMA 1955; 159 : 1602–6. [Google Scholar]
  5. Turner JA, Deyo RA, Loeser JD, et al. The importance of placebo effects in pain treatment and research. JAMA 1994; 271 : 1609–14. [Google Scholar]
  6. Hrobjartsson A, Gotzsche PC. Is the placebo powerless ? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 2001; 344 : 1594–602. [Google Scholar]
  7. De la Fuente-Fernandez R, Schulzer M, Jon Stoessl A. The placebo effect in neurological disorders. Lancet Neurol 2002; 1 : 85–91. [Google Scholar]
  8. Evans FJ. Expectancy, therapeutic instructions and placebo responses. In : Placebo : theory, research and mechanisms. New York : Guilford Press, 1985 : 215–28. [Google Scholar]
  9. Flaten MA, Simonsen T, Olsen H. Drug related information generates placebo and nocebo responses that modify the drug response. Psychosom Med 1999; 61 : 250–5. [Google Scholar]
  10. Kirsch I. Specifying non-specific : psychological mechanism of the placebo effect. In : Harrington A, ed. The placebo effect : an interdisciplinary exploration. Cambridge : Harvard University Press, 1997 : 166–86. [Google Scholar]
  11. Ader R, Cohen N. Behaviorally conditioned immunosuppression and murine systemic lupus erythematous. Science 1982; 215 : 1534–6. [Google Scholar]
  12. Ader R. The role of conditioning in pharmacotherapy. In : Harrington A, ed. The placebo effect : an interdisciplinary exploration. Cambridge : Harvard University Press, 1997 : 138–65. [Google Scholar]
  13. Enserink M. Can the placebo be the cure ? Science 1999; 184 : 238–40. [Google Scholar]
  14. Haour F, Marquette C, Ban E, et al. Interleukin-1 receptors in the central nervous system : role in infection and stress. J Psychiatr Neurosci 1995; 20 : 357–63. [Google Scholar]
  15. Haour F, Dicou E. Interleukin-1 receptors and ligands in the nervous system. In : Saade NE, et al., eds. Pain and neuroimmune interactions. New York : Kluger Academic-Plenum Publisher, 2000 : 157–70. [Google Scholar]
  16. Besedovsky H, Del Rey AE. Immune-neuro-endocrine interactions : facts and hypotheses. Endocrinol Rev 1996; 17 : 64–102. [Google Scholar]
  17. Blalock JE. The syntax of immune-neuroendocrine communication. Immunol Today 1994; 15 : 504–11. [Google Scholar]
  18. Pert CB, Ruff MR, Weber RJ, et al. Neuropeptides and their receptors : a psychosomatic network. J Immunol 1985; 135 : S820–6. [Google Scholar]
  19. Dunn AJ. Mechanisms by which cytokines signal the brain. Int Rev Neurobiol 2002; 52 : 43–65. [Google Scholar]
  20. Goebel MU, Trebst AE, Steiner J, et al. Behavioral conditioning of immunosuppression is possible in humans. FASEB J 2002; 16 : 1869–73. [Google Scholar]
  21. De la Fuente-Fernandez R, Ruth TJ, Sossi V, et al. Expectation and dopamine release : mechanism of the placebo effect in Parkinson’s disease. Science 2001; 293 : 1164–6. [Google Scholar]
  22. De la Fuente-Fernandez R, Jon Stoessl A. The placebo effect in Parkinson’s disease. Trends Neurosci 2002; 25 : 302–6. [Google Scholar]
  23. Kaasinen V, Aalto S, Nägren K, Rinne JO. Expectation of caffeine induces dopaminergic responses in humans. Eur J Neurosci 2004; 19 : 2352–6. [Google Scholar]
  24. Wall PD. The placebo and the placebo response. In : Wall PD, Melzack R, eds. Textbook of pain. New York : Churchill Livingston, 1993 : 1297–308. [Google Scholar]
  25. Exton MS, Schult M, Donath S, et al. Behavioral conditionning prolongs heart allograft survival in rats. Transplant Proc 1998; 30 : 2033. [Google Scholar]
  26. Exton MS, Schult M, Donath S, et al. Conditionned immunosuppression make subtherapeutic cyclosporine effective via splenic innervation. Am J Physiol 1999; 276 : 1710–7. [Google Scholar]
  27. Exton MS, Gierse C, Meier B, et al. Behaviouraly conditioned immunosuppression in the rat is regulated by noradrenaline and beta-adrenoreceptors. J Neuroimmunol 2002; 131 : 21–30. [Google Scholar]
  28. Wolf S. Effect of suggestion and conditioning on the action of the chemical agents in human subjects. The pharmacology of placebos. J Clin Invest 1950; 29 : 100–9. [Google Scholar]
  29. Stockhorst U, Mahl N, Krueger M, et al. Classical conditioning and conditionability of insulin and glucose effect in healthy humans. Physiol Behav 2004; 81 : 375–88. [Google Scholar]
  30. Amanzio M, Benedetti F. Neuropharmacological dissection of placebo analgesia : expectation-activated opioid systems versus conditionning-activated specific subsystems. J Neurosci 1999; 19 : 484–94. [Google Scholar]
  31. Bootzin RR. The role of expectancy in behavior change. In : Placebo, theory, research, and mechanisms. New York : Guilford Press, 1985 : 196–210. [Google Scholar]
  32. Petrovic P, Kalso E, Peterson KM, et al. Placebo and opioid analgesia. Imaging a shared neuronal network. Science 2002; 295 : 1737–40. [Google Scholar]
  33. Zubieta JK, Smith YR, Bueller JA, et al. Mu opioid receptor regulation of sensory and affective dimensions of pain. Science 2001; 293 : 311–5. [Google Scholar]
  34. Wager TD, Rilling JK, Smith EE, et al. Placebo-induced changes in fMRI in the anticipation and experience of pain. Science 2004; 303 : 1162–7. [Google Scholar]
  35. Kirsh I, Sapirstein G. Listening to prozac but hearing placebo. A meta-analysis of antidepressants medication. In : Prevention and treatment, vol. 1. New York : American Psychological Association, 1998. journals.apa.org/prevention [Google Scholar]
  36. Leuchter AF, Cook IA, Witte EA, et al. Changes in brain function of depressed subject during treatment with placebo. Am J Psychiatry 2002; 59 : 122–9. [Google Scholar]
  37. Mayberg HS, Silva JA, Brannan SK, et al. The functional anatomy of the placebo effect. Am J Psychiatry 2002; 159 : 728–37. [Google Scholar]
  38. Jonas WB, Katchup TJ, Linde K. A critical review of homeopathy. Ann Intern Med 2003; 138 : 393–459. [Google Scholar]
  39. Rubi P, Decety J. What you believe versus what you think they believe : a neuroimaging study of conceptual perspective-taking. Eur J Neurosci 2004; 17 : 2475–80. [Google Scholar]
  40. Goldapple K, Segal Z, Garson C, et al. Modulation of cortical-limbique pathways in major depression : treatment specific effects of cognitive behaviour therapy. Arch Gen Psychiatry 2004; 61 : 34–41. [Google Scholar]
  41. Wise RA, Rompre PP. Brain dopamine and reward. Ann Rev Psychol 1989; 40 : 191–225. [Google Scholar]
  42. Schultz W. Predictive reward signal of dopamine neurones. J Neurophysiol 1998; 80 : 1–27. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.